Topic

Texas

A collection of 504 issues

How to Get Xenpozyme (Olipudase Alfa-rpcp) Covered by Blue Cross Blue Shield in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Xenpozyme Covered in Texas Blue Cross Blue Shield of Texas (BCBSTX) typically requires prior authorization for Xenpozyme (olipudase alfa-rpcp) under the medical benefit using HCPCS code J0218. Most approvals require genetic confirmation of acid sphingomyelinase deficiency (ASMD), baseline organ assessments, and specialist oversight. First step today: verify
5 min read

How to Get Xywav (Ca/Mg/K/Na oxybates) Covered by Cigna in Texas: Complete Appeal Guide with Forms and Timelines

Quick Answer: Getting Xywav Covered by Cigna in Texas Cigna requires prior authorization for Xywav (Ca/Mg/K/Na oxybates) with specific clinical criteria. For narcolepsy (≥7 years), you need polysomnography (PSG), multiple sleep latency test (MSLT), and documented failure of dextroamphetamine or contraindications. For idiopathic hypersomnia (≥18 years), trials
6 min read

The Complete Guide to Getting Soliris (Eculizumab) Covered by Cigna in Texas: Forms, Appeals, and Success Strategies

Quick Answer: Getting Soliris (Eculizumab) Covered by Cigna in Texas Cigna requires prior authorization for Soliris using their specific CCRD form with documented FDA-approved diagnosis (PNH, aHUS, gMG, or NMOSD), meningococcal vaccination proof, and REMS enrollment. If denied, Texas residents with fully-insured plans can appeal internally (180 days) and request
6 min read

How to Get Prolastin-C Covered by UnitedHealthcare in Texas: Complete Appeal Guide with Forms and Timelines

Answer Box: Getting Prolastin-C Covered by UnitedHealthcare in Texas Eligibility: You need severe alpha-1 antitrypsin deficiency (PiZZ genotype), documented emphysema on chest CT, and FEV1 between 30-65% predicted. Fastest approval path: Submit prior authorization through UHCprovider.com with complete genotype results, pulmonary function tests, and medical necessity letter. First step
5 min read